Andre Capron
10Patents
4h-index
26Co-inventors
56Inventor score
Filing activity: Jan 27, 1981 → Sep 16, 1999
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6841358B1 | RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY BORDETELLA PERTUSSIS, METHOD FOR PRODUCING SAME, AND USES THEREOF FOR PRODUCING FOREIGN PROTEINS OF VACCINATING ACTIVE PRINCIPLES | Chemistry; Metallurgy | 24 | Expired |
| US5021560A | Immunogenic fraction active against bilharzioses, its preparation, and immunizing compositions containing it | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6660261B1 | Bordetella strain expressing the FHA hybrid, liposomes and vaccines | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5597570A | Protein recognized by antibodies raised against native P28 of schistosoma mansoni | Emerging Cross-Sectional Technologies | 5 | Expired |
| US5824788A | Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications | Chemistry; Metallurgy | 4 | Expired |
| US6392014B1 | Cloning of gene encoding the GP28.5 protein of Toxoplasma gondii; peptide fragments of said protein and their applications | Chemistry; Metallurgy | 3 | Expired |
| US4384992A | Novel peptide from cultures of Schistosoma mansoni, a process for producing it and pharmaceutical compositions containing the same | Emerging Cross-Sectional Technologies | 2 | Expired |
| US5279822A | Monoclonal antibodies against the 28KD protein of S. mansoni | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5071959A | Novel lymphokine for suppressing platelet activation | Emerging Cross-Sectional Technologies | 1 | Expired |
| US5753236A | Antigenic composition obtained by V8 proteolysis of a protein from S. mansoni | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.